Literature DB >> 11202480

Nontuberculous mycobacteria.

S M Holland1.   

Abstract

The nontuberculous mycobacteria are for the most part ubiquitous environmental organisms that only rarely cause disease in humans. Therefore, the normal host defense against these organisms must be quite robust, as exposure is universal and disease is rare. The organisms that are most commonly encountered in clinical practice, Mycobacterium avium, M. intracellulare, M. kansasii, M. fortuitum, M. abscessus, and M. chelonae, are frequently found in water sources and soil. These organisms share significant structural and biochemical similarities with their more pathogenic relative, M. tuberculosis (MTB). Because they are of significantly lower pathogenicity than MTB, patients with abnormal susceptibility to these infections should include those with defects that may be identifiable. Study of these patients should lead to determination of the mechanisms underlying resistance to these organisms, which in turn are likely to be highly informative regarding host defense against these infections and their more virulent relative MTB. Furthermore, recognition of host factors that permit infection with nontuberculous mycobacteria in otherwise normal hosts will identify pathways that can be targeted for therapeutic intervention. Thus, the search for genetic and acquired susceptibility to nontuberculous mycobacteria is also a search for susceptibility factors for MTB as well as an opportunity to recognize endogenous pathways that can be exploited therapeutically.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11202480     DOI: 10.1097/00000441-200101000-00008

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  18 in total

1.  An unusual presentation of mycobacterium fortuitum: massive isolated empyema in a patient with HIV.

Authors:  Afef Agheli; Mohammad Tehranirad; Richard Cofsky
Journal:  MedGenMed       Date:  2006-06-29

2.  PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions.

Authors:  Richard C Huard; Luiz Claudio de Oliveira Lazzarini; W Ray Butler; Dick van Soolingen; John L Ho
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Clinical and prognostic importance of serotyping Mycobacterium avium-Mycobacterium intracellulare complex isolates in human immunodeficiency virus-negative patients.

Authors:  Ryoji Maekura; Yoshinari Okuda; Atsusi Hirotani; Seigo Kitada; Touru Hiraga; Kenji Yoshimura; Ikuya Yano; Kazuo Kobayashi; Masami Ito
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Recurrent mycobacterial infections in a patient with IL-12 deficiency.

Authors:  Matthew Buckland; Roshanara Ali; Graham Bothamley; David Lammas; Rainer Doffinger; Hilary Longhurst
Journal:  BMJ Case Rep       Date:  2009-12-01

5.  Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus.

Authors:  Juan Manuel Belardinelli; Deepshikha Verma; Wei Li; Charlotte Avanzi; Crystal J Wiersma; John T Williams; Benjamin K Johnson; Matthew Zimmerman; Nicholas Whittel; Bhanupriya Angala; Han Wang; Victoria Jones; Véronique Dartois; Vinicius C N de Moura; Mercedes Gonzalez-Juarrero; Camron Pearce; Alan R Schenkel; Kenneth C Malcolm; Jerry A Nick; Susan A Charman; Timothy N C Wells; Brendan K Podell; Jonathan L Vennerstrom; Diane J Ordway; Robert B Abramovitch; Mary Jackson
Journal:  Sci Transl Med       Date:  2022-02-23       Impact factor: 19.319

6.  Rapid-cycle PCR and fluorimetry for detection of mycobacteria.

Authors:  Jacqueline Lachnik; Birgit Ackermann; Antje Bohrssen; Silvia Maass; Catharina Diephaus; Axel Puncken; Marion Stermann; Franz-Christoph Bange
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  A Rhesus Macaque Model of Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  Kevin Winthrop; Andrea Rivera; Flora Engelmann; Sasha Rose; Anne Lewis; Jennifer Ku; Luiz Bermudez; Ilhem Messaoudi
Journal:  Am J Respir Cell Mol Biol       Date:  2016-02       Impact factor: 6.914

8.  Role for lysosomal enzyme beta-hexosaminidase in the control of mycobacteria infection.

Authors:  Ingrid Chou Koo; Yamini M Ohol; Ping Wu; J Hiroshi Morisaki; Jeffery S Cox; Eric J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-07       Impact factor: 11.205

9.  Increased virulence of an epidemic strain of Mycobacterium massiliense in mice.

Authors:  Shaobin Shang; Sara Gibbs; Marcela Henao-Tamayo; Crystal A Shanley; Gerald McDonnell; Rafael Silva Duarte; Diane J Ordway; Mary Jackson
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

10.  Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

Authors:  Hannele Kotilainen; Marja-Liisa Lokki; Riitta Paakkanen; Mikko Seppänen; Pentti Tukiainen; Seppo Meri; Tuija Poussa; Jussi Eskola; Ville Valtonen; Asko Järvinen
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.